SCHEMBL26420402

SCHEMBL26420402

Cc1ccc2[nH]nc(C3CC3)c2c1C(C)(C)Cc1cc(C)c(C(C)(C)C)c2c(N)n[nH]c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22328034 0.79 TLR9 (0.33) —
SCHEMBL20132921 0.77 ROCK2 (0.33) —
SCHEMBL19104285 0.71 PDPK1 (0.42) —
SCHEMBL22924139 0.68 — —
SCHEMBL24854354 0.67 PDPK1 (0.38) —
SCHEMBL22349111 0.66 GRM4 (0.34) —
SCHEMBL22349127 0.66 GAA (0.31) —
SCHEMBL22328057 0.66 PDPK1 (0.41) —
SCHEMBL23879998 0.65 ROCK1 (0.34) —
SCHEMBL24854355 0.65 JAK2 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128824-A1 SPIRO RING-CONTAINING QUINAZOLINE COMPOUND Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2023-04-27 — — US disclosed
Send feedback